Schedule

BioAsia 2025

Hyderabad International Convention Centre (HICC)

25th to 26th Feb 2025

Schedule Plan

BioAsia 2025

DAY – 1 February 25th
9:30 – 10:00 Line Inaugural of International Exhibition
10:00 - 11:00 Line Inaugural Ceremony
  • Shri. Anumula Revanth Reddy, Hon’ble Chief Minister of Telangana
  • Shri. Duddilla Sridhar Babu, Hon’ble Minister for Industries and Commerce, Government of Telangana
  • Dr Jeannette Young AC PSM, Hon’ble Governor of Queensland, Australia
11:00 - 11:20 Line Keynote Address by Mr. Robert A. Bradway, CEO, Amgen
11:20 - 11:40 Line Keynote Address by Prof. Patrick Tan, Executive Director of PRECISE Singapore, Senior Vice Dean (Research) at Duke-NUS Medical School, and Chief Scientific Officer at the Genome Institute of Singapore- Genome Valley Excellence Awardee
11:40 - 12:55 Line Panel Discussion - AI Transformation in Healthcare

Conversation to centre around application of AI across the entire pharma value chain viz R&D, Supply Chain, Operations, Quality, Manufacturing, and Commercialization – both regular Pharmaceuticals and CRDMOs. We will also discuss the future direction for AI integration in healthcare, including vital considerations around cybersecurity, data privacy, and continuous adoption.

    Speakers:
    • Dr. Ken Washington, CTO, Medtronic, USA – Opening Plenary
    • Dr. Nageshwar Reddy, Chairman and Founder, Asian Institute of Gastroenterology (AIG), India
    • Dr. Shyam Bishen, Head, Centre for Health and Healthcare; Member of the Executive Committee, World Economic Forum, Switzerland
    • Dr. Olga Kubassova, President, Image Analysis Group (IAG), UK
    • Dr. Ricardo Gaminha Pacheco, Director, Insilico Medicine, Switzerland
    • Moderator: Chaitanya Royyuru, Partner, EY

    Session Sponsor:

12:55 - 14:00 Line Networking Lunch & Visit to Exhibition
14:00 - 15:15 Line Panel Discussion - Unleashing the tiger: Indian CRDMO sector

    Session Brief: India’s CRDMO market, currently valued at ~$4 billion, is set for rapid growth, driven by China+1 shifts, pricing pressures from the IRA, advancements in new modalities, and a growing focus on local innovation. However, to fully capitalize on this opportunity, the industry must address key challenges—including scaling talent, building a Tier 1 supplier ecosystem, unlocking access to capital, strengthening sustainability measures, and enabling sector-friendly policies and regulations. Success will require stakeholders across the ecosystem (e.g., CRDMO companies, government, Tier 1 suppliers, and global customers) to drive concrete progress. This panel will explore the industry’s potential, barriers, and the critical enablers needed to position India as a global CRDMO powerhouse.

    Speakers:
    • Peter Bains, CEO Designate, Syngene, India
    • Manni Kantipudi, CEO, Aragen Lifesciences, India
    • Krishna Kanumuri, Managing Director & CEO, Sai Lifesciences, India
    • Nandini Piramal, Managing Director, Piramal Lifesciences, India
    • Ramesh Subramaniam, CEO, PI Health Sciences, India
    • Guilano Perfetti, Managing Director & CEO, Jubilant Biosys, Italy
    • Akhil Ravi, CEO, Aurigene Pharmaceutical Services, India
    • Moderator: Mr. Vikash Agarwalla, MD & Partner, BCG, India

    Session Sponsor:

15:15 – 16:30 Line Panel Discussion – Innovations shaping the future of the Global Life Sciences landscape

    Life sciences companies face critical pricing and access issues, with significant revenue at risk from expiring patents, which is pushing them to focus on improving the productivity of their R&D functions through innovations, among other strategies. This panel seeks to explore how innovations like Lab of the Future, AI-driven drug discovery, Digital twins, decentralized and in-silico clinical trials, IOT etc. are redefining the global R&D, Manufacturing, and Supply Chain landscape, driving personalized medicine, and positioning the life sciences sector at the forefront of innovation.

    Speakers:
  • Dr. Boris Stoffel, Managing Director, Miltenyi Biotec, Germany
  • Christian Jones, Chief Commercial Officer, Nanoform, Finland
  • Nitin Dharmadhikari – Chief Operating Officer, SPARC, India
  • Sandhya Sreepathy, Novartis Biomedical Research Head, India
  • Dr. Anil Kaul, Vice President & Head, Global Public Health Discovery, Johnson & Johnson, Belgium
  • Moderator: Peter Lyons, US National Life Sciences Leader, Deloitte

    Moderated by:

    Session Sponsor:

16:30 - 17:30 Line Panel Discussion – Strengthening the Global Bioeconomy and Transforming Human Health Through Generative Biology (In Collaboration with World Economic Forum(WEF))

    Biotechnology stands at a critical juncture, driven by rapid technological progress and shifting global dynamics in healthcare and life sciences. While breakthroughs like generative biology and biomanufacturing have the potential to transform the sector, challenges such as resource limitations, knowledge gaps, and structural disincentives persist. In parallel, Asia—and India in particular—are emerging as leaders in shaping the global biotech landscape, leveraging expertise in manufacturing and healthcare innovation. This session will discuss how the healthcare ecosystem can address barriers, capitalize on opportunities, and position biotechnology as a cornerstone of transformative healthcare solutions.

    Speakers:
  • Dr. Toon Overstijns, CEO, Miltenyi Biomedicine, Germany
  • Dr. Marinna Madrid, Co-Founder & Chief Product Officer, Cellino Biotech, USA
  • Dr. K. Anand Kumar, Managing Director, Indian Immunologicals Limited, India
  • Sanjiv Navangul, Managing Director and CEO, Bharat Serums and Vaccines Ltd, India
  • Prof Ulhas S Kolthur, Director, Centre for DNA Fingerprinting and Diagnostics, India
  • Sai Prasad, Executive Director, Bharat Biotech International Ltd, India
  • Moderator: Brynne Stanton, Bioeconomy Lead, World Economic Forum
  • Session Sponsor:

18:00 - 19:30 Line CEO Conclave - India's Century: Leading the Global Innovation Charge in Life Sciences
    Speakers:
  • Mr. Amitabh Kant, G20 Sherpa, Government of India, India
  • Mr. Satish Reddy, Chairman, Dr. Reddy’s Laboratories, India
  • Mr. Cesar Concepcion, Chief Commercial Officer, APMA region, Novartis, Singapore
  • Mr. Winselow Tucker, President and General Manager, Lilly India
  • Ms. Annapurna Das, General Manager, Takeda India, India
  • Moderator: Govindraj Ethiraj, Founder, IndiaSpend and BOOM
  • CEO Conclave Sponsor:

19:30 Onwards Line Networking Reception
DAY – 2 February 26th
10:30 – 10:50 Line Keynote Address
10:50 – 11:05 Line Plenary Address by Dr. David Reese, Executive Vice President & Chief Technology Officer, Amgen
11:05 – 11:20 Line Plenary Address by Mr. Dave Williams, Chief Information and Digital Officer, MSD
11:20 – 12:25 Line Panel Discussion - Panel Discussion - Life Sciences GCCs - From Cost Arbitrage to Value Arbitrage

    Global Capability Centers (GCCs) in India have evolved from cost-effective operational hubs to strategic drivers of global transformation. No longer just back-office support, they are now at the forefront of accelerating clinical research through advanced analytics, AI-driven insights, and world-class R&D capabilities. Leveraging India’s deep talent pool, GCCs are fostering breakthrough innovations in life sciences and healthcare while also aligning with global ESG priorities by integrating sustainability and governance into their operations. Additionally, they are strengthening resilience and efficiency in global supply chains by harnessing India’s expertise and digital capabilities. This session will explore how GCCs are redefining their role, moving beyond cost efficiency to become centers of excellence, innovation, and strategic value.

    Speakers:
  • John Dawber, Corporate Vice President & Managing Director – Global Business Services, Novo Nordisk, India
  • Siva Padmanabhan, MD & Head of Global Innovation Technology Center, AstraZeneca India, India
  • Puneet Chopra, Head of Data, Digital and Technology (DD&T)Takeda, India
  • Rajiv Onat, India Site Head and Executive Director – Digital Platforms, Regeneron, India
  • Moderator: Dr. Purav Gandhi, Co-Founder &CEO, HealthArk
  • Session Sponsor:

12:25 – 13:30 Line Panel Discussion Panel Discussion – Navigating the Transformative Forces Reshaping the Future of Health:

    The future of health is being dynamically reshaped by a confluence of transformative forces. These include technological advancements, such as artificial intelligence and data interoperability, which are revolutionizing patient care and operational efficiencies. Additionally, demographic shifts, including aging populations and the rise of chronic diseases, are altering healthcare demands and delivery models. Economic pressures and regulatory changes are also driving innovation and necessitating new business models. This panel discussion will delve into these critical forces, highlighting the imperative for life sciences and healthcare stakeholders to adapt and thrive in a rapidly evolving landscape.

    Speakers:
  • Raj Gore, Chief Executive Officer, HCG (Healthcare Global Enterprises Ltd)
  • Dr. Rajendra Pratap Gupta, President, Global Digital Health Corporation
  • Dr. IlankumaranKaliamoorthy, CEO, Rela Hospital
  • Dr Hari Prasad, Group Chairman and Non-Executive Director, CARE Hospitals
  • Alex Koehler, Vice President, Head of Digital, Technology and Innovation, Amgen
  • Moderator: Jerry Bruno - US National Health Care Consulting Leader, Deloitte
13:30 – 14:30 Line Networking Lunch & Visit to Exhibition
14:30 – 15:50 Line Panel Discussions – Clinical Trials - India's great opportunity and how to capture the market

    With clinical trials facing delays and geopolitical shifts disrupting traditional hubs like Russia, Ukraine, and China, India emerges as a promising destination for global trials. Factors such as a growing number of GCCs, large patient population, ability to improve access to medicines. This session delves into India's readiness to seize this opportunity, the key challenges to overcome from a hospital / provider perspective, and how India can position itself as a global leader in efficient, scalable, and high-quality clinical trials.

    Speakers:
  • Ms. Evelin Tiralongo, Director, Clinical Trial Unit, Griffith University, Australia
  • Ms. Sadhna Joglekar, Sr. VP and Head – Novartis Development India, India
  • Mr. Yves Dethier, Founder, Boostcode, Professor in Statistical Analysis and Supply Chain, EPHEC, Belgium
  • Mr. Sanjay Vyas, Country Head India, Parexel, India
  • Ms. Lisa Nelson, CEO, Scientia Clinical Research Limited, Australia
  • Dr. Taruna Madan Gupta, Head Development Research, Indian Council of Medical Research, India
  • Dr. Padmaja Lokireddy, Oncologist, Apollo Hospitals, India
  • Smruthi Suryaprakash, Partner, BCG, India
  • Moderator: Vikas Dandekar, Editor Pharma and Healthcare, ET Prime
  • Session Sponsor:

15:50 – 17:00 Line Panel Discussions – Integrated Healthcare & Patient Outcomes

    Session brief: Focusing on the development of integrated and holistic care models, orchestrated by an ecosystem of the role of technology in improving healthcare access and delivery, the importance of public-private partnerships, and innovative insurance and financing models that can shape the future of healthcare.

    Speakers:
  • Dr Sangita Reddy, Joint Managing Director, Apollo Hospitals, India
  • Dr. Samantha Atkinson, Executive Vice President, NSF Health Sciences & Former Chief Quality & Access Officer, MHRA, UK
  • Dr. Divya Prakash Joshi, Vice President Engineering & Board Member MEIC, Global Technology & Innovation, Medtronic, USA
  • Rajiv Nath, MD, Hindustan Syringes & Medical Devices Ltd & Forum Coordinator AIMED, India
  • Moderator: Suresh Subramaniam, Partner, EY

Session Sponsor:

17:00 – 17:30 Line Valedictory Ceremony